Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.7.11.22 (
cdc2
)
8,319
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
CSB
, a member of the SWI2/SNF2 superfamily, has been implicated in evicting histones to promote the DSB pathway choice towards homologous recombination (HR) repair. However, how
CSB
promotes HR repair remains poorly characterized. Here we demonstrate that
CSB
interacts with both MRE11/RAD50/NBS1 (MRN) and BRCA1 in a cell cycle regulated manner, with the former requiring its WHD and occurring predominantly in early S phase.
CSB
interacts with the BRCT domain of BRCA1 and this interaction is regulated by
CDK
-dependent phosphorylation of
CSB
on S1276. The
CSB
-BRCA1 interaction, which peaks in late S/G2 phase, is responsible for mediating the interaction of
CSB
with the BRCA1-C complex consisting of BRCA1, MRN and CtIP. While dispensable for histone eviction at DSBs,
CSB
phosphorylation on S1276 is necessary to promote efficient MRN- and CtIP-mediated DNA end resection, thereby restricting NHEJ and enforcing the DSB repair pathway choice to HR.
CSB
phosphorylation on S1276 is also necessary to support cell survival in response to DNA damage-inducing agents. These results altogether suggest that
CSB
interacts with BRCA1 to promote DNA end resection for HR repair and that although prerequisite,
CSB
-mediated histone eviction alone is insufficient to promote the pathway choice towards HR.
...
PMID:CSB interacts with BRCA1 in late S/G2 to promote MRN- and CtIP-mediated DNA end resection. 3150 94